Inflammation  >>  Dexycu (dexamethasone intraocular injection)  >>  Phase 2
Welcome,         Profile    Billing    Logout  

2 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Dexycu (dexamethasone intraocular injection) / EyePoint Pharma, Ocumension Therap
NCT01214174: Efficacy and Safety Study of IBI-10090 in Cataract Surgery Patients

Terminated
2
42
US
IBI-10090
ICON Bioscience Inc
Ocular Inflammation
05/12
05/12
NCT01606735: Efficacy and Safety of IBI-10090 in Ocular Surgery Patients

Completed
2
172
US
IBI-10090
ICON Bioscience Inc
Inflammation Associated With Cataract Surgery
03/13
03/13

Download Options